News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
News Conference News PCR London Valves 2022 Registry Results See Less PVL, Pacemakers With Acurate neo2 Shelley Wood November 29, 2022
News Conference News PCR London Valves 2022 Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry Shelley Wood November 28, 2022
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Conference News PCR London Valves 2019 Signal of Impaired Sapien XT Durability in Midterm Follow-up Michael O'Riordan November 20, 2019
News Conference News PCR London Valves 2018 Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady Shelley Wood September 11, 2018
News Conference News PCR London Valves 2018 MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice Shelley Wood September 10, 2018
News Conference News PCR London Valves 2017 CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar Shelley Wood September 28, 2017
News Conference News PCR London Valves 2017 Valve Deterioration and Durability Definitions Now Standardized in New Guide Shelley Wood September 25, 2017
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016
News Conference News PCR London Valves 2016 MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation Shelley Wood September 19, 2016